Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients

Journal of the American Academy of Dermatology

Volumn 34, Issue 4, 1996, Pages 626-631

  Zackheim, H S ^a   Kashani Sabet, M ^a   Hwang, S T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; ERYTHRODERMA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LEUKOPENIA; MALE; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PRURITUS; SEZARY CELL; T CELL LYMPHOMA; THROMBOCYTOPENIA; TREATMENT FAILURE; VERTIGO;

EID: 0029913175     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)80062-4     Document Type: Article

References (17)

1. Wieselthier JS Koh HK Sézary syndrome: diagnosis, prognosis, and critical review of treatment options J Am Acad Dermatol 22 1990 381 401
2. Sausville EA Eddy JL Makuch RW Histopathologc staging at initial diagnosis of mycosis fungoides and the Sézary syndrome: definition of three distinctive prognostic groups Ann Intern Med 109 1988 372 382
3. Abel EA Wood GS Hoppe RT Mycosis fungoides: clinical and histologic features, staging, evaluation, and approach to treatment CA Cancer J Clin 43 1993 93 115
4. Zackheim HS Epstein EH Jr. Low-dose methotrexate for the Sézary syndrome J Am Acad Dermatol 21 1989 757 762
5. LeBoit PE Abel EA Cleary ML Clonal rearrangement of the T cell receptor gene in the circulating lymphocytes of erythrodermic follicular mucinosis Blood 71 1988 1329 1333
6. Fletcher V Zackheim HS Beckstead JH Circulating Sézary cells: a new preparatory method for their identification and enumeration Arch Pathol Lab Med 108 1984 954 958
7. Kaplan EL Meier T Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 482
8. Zackheim HS Subcutaneous administration of methotrexate J Am Acad Dermatol 26 1992 1008
9. Roenigk HH Jr Auerbach R Maibach HI Methotrexate in psoriasis: revised guidelines J Am Acad Dermatol 19 1988 145 156
10. Anderson JR Propert KJ Harrington DP Guidelines for reporting outcomes of lymphoma trials J Clin Oncol 6 1988 559 560
11. Dixon DO McLaughlin P Hagemeister FB Reporting outcomes in Hodgkin's disease and lymphoma J Clin Oncol 5 1987 1670 1672
12. Dixon DO McLaughlin P Hagemeister FB Reply [Letter] J Clin Oncol 6 1988
13. JR Anderson KJ Propert DP Harrington Guidelines for reporting outcomes of lymphoma trials J Clin Oncol 6 1988 559 560 In response to
14. Bernengo MG Appino A Bertero M Thymopentin in Sézary syndrome J Natl Cancer Inst 84 1992 1341 1346
15. Markman M Why does a higher response rate to chemotherapy correlate poorly with improved survival? J Cancer Res Clin Oncol 119 1993 700 701
16. Vonderheid EC Van Scott EJ Wallner PE A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy Cancer Treat Rep 63 1979 681 689
17. Zackheim HS Epstein EH Jr Crain WR Topical carmustine (BCNU) for cutaneous T-cell lymphoma: a 15-year experience in 143 patients J Am Acad Dermatol 22 1990 802 810